REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cde Laboratorios S.A.S. (Colombia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Cde Laboratorios S.A.S. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

The company Cde Laboratorios S.A.S. is primarily engaged in pharmaceutical and medicine manufacturing and related activities. It's been operating in the Colombian market since 2002.

Headquarters
Aut Medellin Km 3.5 Mod 2 Bod 32 Cem Siberia Cota
Cota; Cundinamarca;

Contact Details: Purchase the Cde Laboratorios S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Cde Laboratorios S.A.S. report to view the information.
Outstanding Shares:
Purchase the Cde Laboratorios S.A.S. report to view the information.
Incorporation Date:
July 04, 2002
Key Executives
Purchase this report to view the information.
Legal Representative
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Purchase this report to view the information.
Deputy Member of the Board of Directors
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after Cde Laboratorios S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
12.68%▲
Total operating revenue
14.24%▲
Operating profit (EBIT)
-37.02%▼
EBITDA
-22.87%▼
Net Profit (Loss) for the Period
-79.84%▼
Total assets
-7.08%▼
Total equity
3.23%▲
Operating Profit Margin (ROS)
-3.76%▼
Net Profit Margin
-5.28%▼
Return on Equity (ROE)
-12.88%▼
Debt to Equity Ratio
-13.54%▼
Quick Ratio
0.13%▲
Cash Ratio
0.08%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo